These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1354275)

  • 1. Randomised controlled trial of adjuvant chemotherapy by portal-vein perfusion after curative resection for colorectal adenocarcinoma.
    Fielding LP; Hittinger R; Grace RH; Fry JS
    Lancet; 1992 Aug; 340(8818):502-6. PubMed ID: 1354275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic overview of chemotherapy effects in colorectal cancer.
    Ragnhammar P; Hafström L; Nygren P; Glimelius B;
    Acta Oncol; 2001; 40(2-3):282-308. PubMed ID: 11441937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant portal liver infusion in colorectal cancer with 5-fluorouracil/heparin versus urokinase versus control. Results of a prospective randomized clinical trial (colorectal adenocarcinoma trial I).
    Wereldsma JC; Bruggink ED; Meijer WS; Roukema JA; van Putten WL
    Cancer; 1990 Feb; 65(3):425-32. PubMed ID: 2404556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant perioperative portal vein or peripheral intravenous chemotherapy for potentially curative colorectal cancer: long-term results of a randomized controlled trial.
    Laffer U; Metzger U; Aeberhard P; Lorenz M; Harder F; Maibach R; Zuber M; Herrmann R
    Int J Colorectal Dis; 2008 Dec; 23(12):1233-41. PubMed ID: 18688620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Final results of a phase III clinical trial on adjuvant intraportal infusion with heparin and 5-fluorouracil (5-FU) in resectable colon cancer (EORTC GITCCG 1983-1987). European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group.
    Nitti D; Wils J; Sahmoud T; Curran D; Couvreur ML; Lise M; Rauschecker H; dos Santos JG; Stremmel W; Roelofsen F
    Eur J Cancer; 1997 Jul; 33(8):1209-15. PubMed ID: 9301444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant portal-vein infusion of fluorouracil and heparin in colorectal cancer: a randomised trial. European Organisation for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group, the Gruppo Interdisciplinare Valutazione Interventi in Oncologia, and the Japanese Foundation for Cancer Research.
    Rougier P; Sahmoud T; Nitti D; Curran D; Doci R; De Waele B; Nakajima T; Rauschecker H; Labianca R; Pector JC; Marsoni S; Apolone G; Lasser P; Couvreur ML; Wils J
    Lancet; 1998 Jun; 351(9117):1677-81. PubMed ID: 9734883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of single course of adjuvant intraportal chemotherapy for colorectal cancer. Swiss Group for Clinical Cancer Research (SAKK).
    Lancet; 1995 Feb; 345(8946):349-53. PubMed ID: 7845115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant therapy of Dukes' A, B, and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: preliminary results of National Surgical Adjuvant Breast and Bowel Project Protocol C-02.
    Wolmark N; Rockette H; Wickerham DL; Fisher B; Redmond C; Fisher ER; Potvin M; Davies RJ; Jones J; Robidoux A
    J Clin Oncol; 1990 Sep; 8(9):1466-75. PubMed ID: 2202789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of portal vein chemotherapy on liver metastasis after surgical resection of colorectal cancer.
    Yu DS; Li Y; Huang XE; Lu YY; Wu XY; Liu J; Cao J; Xu X; Xiang J; Wang GP
    Asian Pac J Cancer Prev; 2012; 13(9):4699-701. PubMed ID: 23167405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparing the effect of adjuvant chemotherapy by portal vein infusion with intraluminal chemotherapy for colorectal cancer].
    Pan ZZ; Wan DS; Lu ZH; Li LR; Chen G; Zhou ZW; Wu XJ; Ding PR; Wang FL
    Zhonghua Wai Ke Za Zhi; 2004 Aug; 42(15):918-21. PubMed ID: 15363253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant therapy for resectable colorectal carcinoma with fluorouracil administered by portal vein infusion. A study of the Mayo Clinic and the North Central Cancer Treatment Group.
    Beart RW; Moertel CG; Wieand HS; Leigh JE; Windschitl HE; van Heerden JA; Fitzgibbons RJ; Wolff BG
    Arch Surg; 1990 Jul; 125(7):897-901. PubMed ID: 2369315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large scale trial for adjuvant treatment in high risk resected colorectal cancers. Rationale to test the combination of loco-regional and systemic chemotherapy and to compare l-leucovorin + 5-FU to levamisole + 5-FU.
    Rougier P; Nordlinger B
    Ann Oncol; 1993; 4 Suppl 2():21-8. PubMed ID: 8353101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early hematological toxicity of adjuvant perioperative intraportal and intravenous chemotherapy with fluorouracil, mitomycin and heparin in colorectal cancer. Swiss Group for Clinical Cancer Research.
    Weber W; Maibach R; Laffer U; Metzger U; Egeli R; Lorenz M; Aeberhard P; Dupont-Lampert V; Nöthiger F; Rüed T
    Anticancer Res; 1995; 15(5B):2197-200. PubMed ID: 8572624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Final results of a randomized clinical trial of adjuvant intraportal chemotherapy for colorectal cancer: Intraportal Chemotherapy for Colorectal Cancer Group].
    Yamamura T; Yabe K; Oka H; Kouzuma T; Kawahara H; Wakayama T; Sugiura A; Hagiwara M; Ohdate K; Miyajima N; Maeda C; Okamura R; Miyahara T; Moriyama Y; Yamaguchi S; Gunji A;
    Gan To Kagaku Ryoho; 2002 Oct; 29(10):1765-71. PubMed ID: 12402427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of intraportal and/or systemic adjuvant chemotherapy in patients with colon carcinoma.
    Labianca R; Fossati R; Zaniboni A; Torri V; Marsoni S; Nitti D; Boffi L; Scatizzi M; Tardio B; Mastrodonato N; Banducci S; Consani G; Pancera G;
    J Natl Cancer Inst; 2004 May; 96(10):750-8. PubMed ID: 15150303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locoregional chemotherapy for adjuvant treatment of colorectal adenocarcinoma.
    Penna C; Nordlinger B
    Eur J Cancer; 1996 Jun; 32A(7):1117-22. PubMed ID: 8758240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized multicenter trial of adjuvant intraportal chemotherapy for colorectal cancer (SAKK 40/81). An interim report.
    Metzger U; Laffer U; Aeberhard P; Arigoni M; Arma S; Barras J; Egeli R; Martinoli S; Mueller W; Schweizer W
    Acta Chir Scand; 1990; 156(6-7):467-74. PubMed ID: 2114722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The presence of a systemic inflammatory response predicts poorer survival in patients receiving adjuvant 5-FU chemotherapy following potentially curative resection for colorectal cancer.
    Crozier JE; McKee RF; McArdle CS; Angerson WJ; Anderson JH; Horgan PG; McMillan DC
    Br J Cancer; 2006 Jun; 94(12):1833-6. PubMed ID: 16721360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Portal vein chemotherapy for colorectal cancer: a meta-analysis of 4000 patients in 10 studies. Liver Infusion Meta-analysis Group.
    J Natl Cancer Inst; 1997 Apr; 89(7):497-505. PubMed ID: 9086006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.